3 reasons why I think the Sonic Healthcare share price is a strong buy

Looking for healthy returns? Have a look at this leader.

| More on:
Two researchers discussing results of a study with each other.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Sonic Healthcare is a leading pathology business in Australia, Germany and the United States
  • It’s experiencing solid organic growth of its non-COVID revenue
  • The company is seeing increased profits and continues to make appealing bolt-on acquisitions

The Sonic Healthcare Limited (ASX: SHL) share price has rallied 20% in 2023 to date. I think there are a number of reasons to be positive about further potential growth.

The ASX healthcare share is a leading pathology company not just here in Australia but also in the United States, Germany, Switzerland and the United Kingdom. It's building a strong position in radiology in Australia.

Healthcare is widely regarded as a defensive sector because people don't choose when they get sick or need medical help.

Sonic Healthcare, in particular, appears to be a solid business, and pathology is an integral part of the healthcare system.

I think the Sonic Healthcare share price can continue to deliver good returns from here for a number of different reasons. Let's dig deeper.

Strong organic growth

A key part of a company's ability to achieve good returns is the level of organic growth that it's able to achieve. In other words, is the core business growing well without needing acquisitions?

COVID-19 testing revenue helped Sonic Healthcare deliver strong revenue and earnings but was unlikely to last forever.

So, is the non-COVID revenue growing well? Yes. In the first six months of the FY23 half-year result, the company's 'base business' revenue grew by 6% year over year. January 2023 base business revenue saw 14% growth year over year.

A portion of that good growth may be explained by 'catch-up' testing now that life has largely returned to normal after the pandemic. But, the organic growth is very positive.

I think it suggests that net profit after tax (NPAT) can keep growing at a good pace, particularly if it can keep achieving increasing scale benefits. And that's good news for the Sonic Healthcare share price.

Increased profitability, partly thanks to acquisitions

The ASX healthcare share is now much more profitable in the aftermath of COVID-19 disruptions.

Compared to the pre-pandemic period of the first half of FY20, the HY23 total revenue was 22% higher, earnings before interest, tax, depreciation and amortisation (EBITDA) was up 33%, operating cash flow was 47% higher, and NPAT had increased 50%.

Sonic has used acquisitions to grow the business in Australia and around the world, which adds to the company's organic (market share) growth. For example, it recently announced the €180 million acquisition of Medical Laboratories Dusseldorf in Germany, which is expected to generate around €50 million of revenue in FY24.

I'm also excited by the company's involvement in artificial intelligence, which could be very useful for future pathology.

Good dividend growth

The ASX healthcare share has a "progressive dividend" policy as well. In other words, it aims to grow its dividend each result for shareholders.

In the HY23 result, the business grew the dividend payment for shareholders by 5% to 42 cents per share at the current Sonic Healthcare share price.

Using the last two dividends, Sonic Healthcare currently has a grossed-up dividend yield of 4.1%. That's a solid yield, in my opinion.

The dividends can provide regular and growing cash returns for investors, while profit can hopefully grow.

Foolish takeaway

Using the estimates on Commsec, the Sonic Healthcare share price is valued at 23x FY23's forecast profit. I think that adds up to a good price considering its very defensive characteristics.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Defensive Shares

A couple makes silly chip moustache faces and take a selfie on their phone.
Blue Chip Shares

3 blue-chip ASX shares I think are so safe you could hold them forever

No shares are 'safe', but some are safer than others.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Defensive Shares

Why I'd buy these top defensive ASX shares before Christmas

These stocks could be compelling picks in the next few months.

Read more »

rising asx share price represented by man with arms raised against blackboard featuring images of dollar notes
Defensive Shares

I'll be investing $5,000 in this defensive ASX stock following its first-class result

This is one ASX share that has products customers can't seem to live without...

Read more »

Two mature women learn karate for self defence.
Defensive Shares

2 defensive ASX shares for lower-risk investors

I think any investor can comfortably add these two shares to a portfolio today...

Read more »

Man drinking from a bottle sitting on a floating ring in the middle of a harbour going nowhere.
Defensive Shares

2 ASX shares to confidently buy now and hold forever

Long-term thinking is the key with these two ASX names.

Read more »

Two mature women learn karate for self defence.
Defensive Shares

2 recession-proof ASX shares to buy in August

These stocks could be two of the most defensive on the ASX.

Read more »

a woman pushes a man standing in a shopping trolley pointing ahead far off into the distance.
Defensive Shares

1 reliable ASX stock I'd be as happy as Larry to hold through a recession

Here's my pick for a recession-resistant ASX share to buy today.

Read more »

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Defensive Shares

AML3D share price surges another 38% today! What's going on?

The defence sector is catching some strong bids.

Read more »